Biogen: Earnings Beat Expectations, Maintaining Current Fair Value Estimate By: Morningstar Article July 21, 2016 at 14:00 PM EDT Despite CEO uncertainty, we remain confident in the firm's wide moat and competitive advantages in neurology. Read More >>